
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $414.7M | -- | -- | $2.24 | -- |
07/24/2025 | Q2 | $411M | -- | -- | $2.20 | -- |
04/24/2025 | Q1 | $401.8M | $402.3M | $2.10 | $2.11 | -$0.01 |
02/06/2025 | Q4 | $394.9M | $395.4M | $2.00 | $2.00 | -$0.00 |
10/24/2024 | Q3 | $390.2M | $390.6M | $2.07 | $2.01 | $0.06 |
07/25/2024 | Q2 | $385.8M | $387.1M | $2.01 | $1.93 | $0.08 |
04/25/2024 | Q1 | $381.8M | $384.3M | $1.92 | $1.87 | $0.05 |
02/08/2024 | Q4 | $377.9M | $380.4M | $2.60 | $1.86 | $0.74 |
10/26/2023 | Q3 | -- | -- | $1.83 | $1.80 | $0.03 |
07/27/2023 | Q2 | -- | -- | $1.79 | -- | -- |
04/27/2023 | Q1 | -- | -- | $1.70 | -- | -- |
02/09/2023 | Q4 | -- | -- | $1.70 | -- | -- |
10/27/2022 | Q3 | -- | -- | $1.58 | -- | -- |
07/28/2022 | Q2 | -- | -- | $1.54 | -- | -- |
04/28/2022 | Q1 | -- | -- | $1.43 | $1.51 | -$0.08 |
02/10/2022 | Q4 | -- | -- | $2.97 | $1.38 | $1.59 |
10/28/2021 | Q3 | -- | -- | $1.40 | $1.41 | -$0.01 |
07/22/2021 | Q2 | -- | -- | $1.31 | $1.36 | -$0.05 |
04/22/2021 | Q1 | -- | -- | $1.33 | $1.33 | $0.00 |
02/11/2021 | Q4 | -- | -- | $1.38 | $1.34 | $0.04 |
10/22/2020 | Q3 | -- | -- | $1.49 | $1.35 | $0.14 |
07/23/2020 | Q2 | -- | -- | $1.32 | $1.32 | $0.00 |
04/23/2020 | Q1 | -- | -- | $2.86 | $1.26 | $1.60 |
02/06/2020 | Q4 | -- | -- | $1.26 | $1.33 | -$0.07 |
10/24/2019 | Q3 | -- | -- | $1.30 | $1.31 | -$0.01 |
07/25/2019 | Q2 | -- | -- | $1.33 | $1.29 | $0.04 |
04/25/2019 | Q1 | -- | -- | $1.31 | $1.25 | $0.06 |
02/07/2019 | Q4 | -- | -- | $1.58 | $1.21 | $0.37 |
10/25/2018 | Q3 | -- | -- | $1.23 | $1.19 | $0.04 |
07/26/2018 | Q2 | -- | -- | $1.18 | $1.13 | $0.05 |
04/26/2018 | Q1 | -- | -- | $1.07 | $1.06 | $0.01 |
02/08/2018 | Q4 | -- | -- | $0.96 | $0.97 | -$0.01 |
10/26/2017 | Q3 | -- | -- | $1.00 | $0.99 | $0.01 |
07/27/2017 | Q2 | -- | -- | $1.05 | $0.99 | $0.06 |
04/27/2017 | Q1 | -- | -- | $0.96 | $0.94 | $0.02 |
02/09/2017 | Q4 | -- | -- | $0.92 | $0.88 | $0.04 |
10/27/2016 | Q3 | -- | -- | $0.83 | $0.79 | $0.04 |
07/28/2016 | Q2 | -- | -- | $0.87 | -- | -- |
04/28/2016 | Q1 | -- | -- | $0.77 | -- | -- |
02/11/2016 | Q4 | -- | -- | $0.77 | -- | -- |
10/22/2015 | Q3 | -- | -- | $0.72 | -- | -- |
VeriSign reported $402.3M worth of top line sales in its most recent quarter.
VeriSign announced earnings per share of $2.10 which represents a miss of analyst forecast a $2.11 per share.
VeriSign reported $352.9M that represents $3.72 per share over the last quarter.
VeriSign's earnings are forecast to grow from $8.00 per share to $8.02 per share next year representing an increase of 10%.
VeriSign's next earnings date is July 24, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.